| The king cobra genome reveals dynamic gene evolution and adaptation in the snake venom system FJ Vonk, NR Casewell, CV Henkel, AM Heimberg, HJ Jansen, ... Proceedings of the National Academy of Sciences 110 (51), 20651-20656, 2013 | 533 | 2013 |
| Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift AM Hopkins, JM Logan, G Kichenadasse, MJ Sorich JNCI cancer spectrum 7 (2), pkad010, 2023 | 211 | 2023 |
| Fluorescence microscopy—an outline of hardware, biological handling, and fluorophore considerations SM Hickey, B Ung, C Bader, R Brooks, J Lazniewska, IRD Johnson, ... Cells 11 (1), 35, 2021 | 78 | 2021 |
| Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150 AM Hopkins, G Kichenadasse, RA McKinnon, AY Abuhelwa, JM Logan, ... British Journal of Cancer 126 (1), 42-47, 2022 | 59 | 2022 |
| Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer C Martini, JM Logan, A Sorvina, C Gordon, AR Beck, BSY Ung, ... Pathology 55 (1), 40-51, 2023 | 21 | 2023 |
| Evaluation of small molecule drug uptake in patient-derived prostate cancer explants by mass spectrometry SM Mutuku, PJ Trim, BK Prabhala, S Irani, KL Bremert, JM Logan, ... Scientific reports 9 (1), 15008, 2019 | 19 | 2019 |
| A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies ND Modi, G Kichenadasse, TC Hoffmann, M Haseloff, JM Logan, ... BMC medicine 21 (1), 400, 2023 | 15 | 2023 |
| The effect of proton pump inhibitors on survival outcomes in advanced hepatocellular carcinoma treated with sorafenib W Ruanglertboon, MJ Sorich, JM Logan, A Rowland, AM Hopkins Journal of cancer research and clinical oncology 146, 2693-2697, 2020 | 15 | 2020 |
| Pitfalls in cutaneous melanoma diagnosis and the need for new reliable markers GT Lam, S Prabhakaran, A Sorvina, C Martini, BSY Ung, L Karageorgos, ... Molecular Diagnosis & Therapy 27 (1), 49-60, 2023 | 13 | 2023 |
| Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression J Lazniewska, KL Li, IRD Johnson, A Sorvina, JM Logan, C Martini, ... Scientific reports 13 (1), 13489, 2023 | 11 | 2023 |
| A literature review of treatment-specific clinical prediction models in patients with breast cancer ND Modi, MJ Sorich, A Rowland, JM Logan, RA McKinnon, ... Critical Reviews in Oncology/Hematology 148, 102908, 2020 | 11 | 2020 |
| Prediction of prostate cancer biochemical and clinical recurrence is improved by IHC-assisted grading using Appl1, Sortilin and Syndecan-1 JM Logan, AM Hopkins, C Martini, A Sorvina, P Tewari, S Prabhakaran, ... Cancers 15 (12), 3215, 2023 | 10 | 2023 |
| Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread A Sorvina, C Martini, S Prabhakaran, JM Logan, BSY Ung, C Moore, ... Pathology 55 (6), 792-799, 2023 | 8 | 2023 |
| TLR7 promotes chronic airway disease in RSV-infected mice MA Miles, S Liong, F Liong, M Coward-Smith, GS Trollope, OO Oseghale, ... Frontiers in Immunology 14, 1240552, 2023 | 6 | 2023 |
| A paradigm in immunochemistry, revealed by monoclonal antibodies to spatially distinct epitopes on syntenin-1 IRD Johnson, A Sorvina, JM Logan, CR Moore, JK Heatlie, ... International Journal of Molecular Sciences 20 (23), 6035, 2019 | 6 | 2019 |
| Primary predictors of survival outcomes for HER2-positive advanced breast cancer patients initiating ado-trastuzumab emtansine AM Hopkins, A Rowland, JM Logan, MJ Sorich The Breast 46, 90-94, 2019 | 6 | 2019 |
| Smoking and immunotherapy efficacy in lung cancer by PDL1 subgroups: An individual participant data meta-analysis of atezolizumab clinical trials: Smoking and immunotherapy … AM Hopkins, AY Abuhelwa, RA McKinnon, JM Logan, G Kichenadasse, ... European Journal of Cancer 160, 279-281, 2022 | 5 | 2022 |
| Altered expression of vesicular trafficking machinery in prostate cancer affects lysosomal dynamics and provides insight into the underlying biology and disease progression BD Nturubika, CM Guardia, DC Gershlick, JM Logan, C Martini, JK Heatlie, ... British Journal of Cancer 131 (8), 1263-1278, 2024 | 4 | 2024 |
| Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: a spotlight on the contribution of the endosome-lysosome system J Tang, GT Lam, RD Brooks, M Miles, Z Useckaite, IRD Johnson, ... Cancer Letters 585, 216639, 2024 | 4 | 2024 |
| Insights into melanoma clinical practice: a perspective for future research GT Lam, C Martini, T Brooks, S Prabhakaran, AM Hopkins, BSY Ung, ... Cancers 15 (18), 4631, 2023 | 3 | 2023 |